Longevity Health Holdings Merges With Thplasma, Ends 20/20 Biolabs Deal
Longevity Health Holdings (Nasdaq: XAGE), a company focused on longevity and healthy aging, is merging with True Health Inc....
Longevity Health Holdings (Nasdaq: XAGE), a company focused on longevity and healthy aging, is merging with True Health Inc....
Branded Legacy Inc. is undergoing a rapid transformation, shifting its focus from plant-based wellness and cannabis beverages to the...
Ttam Research Institute, a non-profit led by Anne Wojcicki, has finalized its acquisition of 23andMe’s personal genome service and...
Salarius Pharmaceuticals has received another extension from Nasdaq, pushing the deadline for regaining compliance with minimum bid price and...
Iovance Biotherapeutics’ real-world data reinforces the clinical value of Lifileucel (amtagvi) in advanced melanoma. The recently released data from...
Rakovina Therapeutics’ partner, Variational AI, has been awarded the 2025 Emerging Company of the Year – Biotech by Life...
Biogen and Stoke Therapeutics have presented new data on zorevunersen, their investigational antisense oligonucleotide for Dravet syndrome, further solidifying...
Telix Pharmaceuticals has secured a permanent Healthcare Common Procedure Coding System (HCPCS) Level II code (A9616) from the U.S....
Nurix Therapeutics, a clinical-stage biotech focused on targeted protein degradation, reported positive financial results for Q2 2025, driven by...
XOMA Royalty Corporation will acquire Turnstone Biologics for $0.34 per share in cash plus one non-transferable contingent value right...